Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events After Acute Kidney Injury

Background The mechanisms underlying long-term sequelae following acute kidney injury (AKI) remain unclear. Vessel instability, an early response to endothelial injury, may reflect a shared mechanism and early trigger for chronic kidney disease (CKD) and heart failure. Methods To investigate whether plasma angiopoietins, markers of vessel homeostasis, are associated with CKD progression and heart failure admissions after hospitalization in patients with and without AKI, we conducted a prospective cohort study to analyze the balance between angiopoietin-1 (Angpt-1), which maintains vessel stability, and angiopoietin-2 (Angpt-2), which increases vessel destabilization. Three months after discharge, we evaluated the associations between angiopoietins and development of the primary outcomes of CKD progression and heart failure, as well as the secondary outcome of all-cause mortality 3 months after discharge or later. Results Median age for the 1503 participants was 65.8 years; 746 (50%) had AKI. Compared with the lowest quartile, the highest quartile of the Angpt-1:Angpt-2 ratio was associated with 72% lower risk of CKD progression (adjusted hazard ratio [aHR], 0.28; 95% confidence interval [95% CI], 0.15 to 0.51), 94% lower risk of heart failure (aHR, 0.06; 95% CI, 0.02 to 0.15), and 82% lower risk of mortality (aHR, 0.18; 95% CI, 0.09 to 0.35) for those with AKI. Among those without AKI, the highest quartile of Angpt-1:Angpt-2 ratio was associated with 71% lower risk of heart failure (aHR, 0.29; 95% CI, 0.12 to 0.69) and 68% less mortality (aHR, 0.32; 95% CI, 0.15 to 0.68). There were no associations with CKD progression. Conclusions A higher Angpt-1:Angpt-2 ratio was strongly associated with less CKD progression, heart failure, and mortality in the setting of AKI.

Indicators of the critical state of the ship’s stability

According to the main criterion, the vessel stability according to the main criterion is standardized by the Rules of the Russian Register by the assumption that the units of the stability margin are practically equal, which is the ratio of listing and restoring moments characterizing the equality of their work. That is, the current domestic and international standards allow the achievement of a shipborne borderline hazardous state, after which it will either capsize, or an uncontrolled inflow of water into the hull and emergency flooding will begin. The characteristics of the vessel that affect stability during its assessment, both at the design stages and during operation, are determined with some error. It is caused by the assumptions of the Rules to the displacement value determination and the coordinates of the gravity center, incomplete compliance with the predicted cruise conditions, due to the ship falling into possible more severe conditions, the construction of a static stability diagram, which is the dependence of the reduced restoring moment on the inclination angle, with a flat waterline, while it is three-dimensional, and other factors related to the vessel’s type and purpose, which are not taken into account when calculating stability. In this paper, we consider a group of such factors, in relation to ships of inland and mixed (river-sea) navigation, the features and reasons for their occurrence, taking into account in verification calculations. A mathematical stability safety factor form, reflecting the expected increments of permissible values, which will improve the safety of the ship, is proposed.

Jellyfishing in Europe: Current Status, Knowledge Gaps, and Future Directions towards a Sustainable Practice

Jellyfish are often described as a nuisance species, but as our understanding shifts to more ecosystem-based conceptions, they are also recognized as both important components of marine ecosystems and a resource for humans. Here, we describe global jellyfish fisheries and review production, fishing methods, and applications based on the existing literature. We then focus on future development of a European jellyfish fishery based on current and recent EU research initiatives. Jellyfish have been a staple food in East Asia for eons and now show a potential for non-food applications as well. The main fishing methods are mostly traditional, with set-nets, driftnets, hand-nets, and scoop-nets utilizing small crafts or beach-seines. All require a lot of manual labor, thus providing vital, albeit seasonal, occupation to weaker populations. Larger commercial vessels such as purse seines and trawlers are newly introduced métiers which may enable a larger catch per unit effort and total catch, but pose questions of selectivity, bycatch, vessel stability, and transshipment. Social concerns arising from the seasonality of jellyfish fisheries must be met in SE Asia, Latin America, and in any location where new fisheries are established. In the EU, we recognize at least 15 species showing potential for commercial harvesting, but as of 2021, a commercial fishery has yet to be developed; as in finfish fisheries, we advise caution and recognition of the role of jellyfish in marine ecosystems in doing so. Sustainable harvesting techniques and practices must be developed and implemented for a viable practice to emerge, and social and ecological needs must also be incorporated into the management plan. Once established, the catch, effort, and stock status must be monitored, regulated, and properly reported to FAO by countries seeking a viable jellyfish fishery. In the near future, novel applications for jellyfish will offer added value and new markets for this traditional resource.

Matricellular Protein SPARCL1 Regulates Blood Vessel Integrity and Antagonizes Inflammatory Bowel Disease

Background The understanding of vascular plasticity is key to defining the role of blood vessels in physiologic and pathogenic processes. In the present study, the impact of the vascular quiescence marker SPARCL1 on angiogenesis, capillary morphogenesis, and vessel integrity was evaluated. Methods Angiogenesis was studied using the metatarsal test, an ex vivo model of sprouting angiogenesis. In addition, acute and chronic dextran sodium sulfate colitis models with SPARCL1 knockout mice were applied. Results This approach indicated that SPARCL1 inhibits angiogenesis and supports vessel morphogenesis and integrity. Evidence was provided that SPARCL1-mediated stabilization of vessel integrity counteracts vessel permeability and inflammation in acute and chronic dextran sodium sulfate colitis models. Structure-function analyses of purified SPARCL1 identified the acidic domain of the protein necessary for its anti-angiogenic activity. Conclusions Our findings inaugurate SPARCL1 as a blood vessel–derived anti-angiogenic molecule required for vessel morphogenesis and integrity. SPARCL1 opens new perspectives as a vascular marker of susceptibility to colitis and as a therapeutic molecule to support blood vessel stability in this disease.

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

Angiopoietin-2 (Ang-2), a ligand of the tyrosine kinase receptor Tie2, is essential for vascular development and blood vessel stability and is also involved in monocyte activation. Here, we examined the role of Ang-2 on monocyte activation in patients with systemic sclerosis (SSc). Ang-2 levels were measured in serum and skin of healthy controls (HCs) and SSc patients by ELISA and array profiling, respectively. mRNA expression of ANG2 was analyzed in monocytes, dermal fibroblasts, and human pulmonary arterial endothelial cells (HPAECs) by quantitative PCR. Monocytes were stimulated with Ang-2, or with serum from SSc patients in the presence of a Tie2 inhibitor or an anti-Ang2 neutralizing antibody. Interleukin (IL)-6 and IL-8 production was analyzed by ELISA. Ang-2 levels were elevated in the serum and skin of SSc patients compared to HCs. Importantly, serum Ang-2 levels correlated with clinical disease parameters, such as skin involvement. Lipopolysaccharide (LPS) LPS, R848, and interferon alpha2a (IFN-α) stimulation up-regulated the mRNA expression of ANG2 in monocytes, dermal fibroblasts, and HPAECs. Finally, Ang-2 induced the production of IL-6 and IL-8 in monocytes of SSc patients, while the inhibition of Tie2 or the neutralization of Ang-2 reduced the production of both cytokines in HC monocytes stimulated with the serum of SSc patients. Therefore, Ang-2 induces inflammatory activation of SSc monocytes and neutralization of Ang-2 might be a promising therapeutic target in the treatment of SSc.